rs17687109

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 1P and 18B. PP2BP4_ModerateBP6_Very_StrongBA1

The ENST00000622264.4(GALC):​c.1187T>C​(p.Leu396Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.141 in 1,595,282 control chromosomes in the GnomAD database, including 17,208 homozygotes. In-silico tool predicts a benign outcome for this variant. 6/6 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1141 hom., cov: 32)
Exomes 𝑓: 0.14 ( 16067 hom. )

Consequence

GALC
ENST00000622264.4 missense

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.0150

Publications

26 publications found
Variant links:
Genes affected
GALC (HGNC:4115): (galactosylceramidase) This gene encodes a lysosomal protein which hydrolyzes the galactose ester bonds of galactosylceramide, galactosylsphingosine, lactosylceramide, and monogalactosyldiglyceride. Mutations in this gene have been associated with Krabbe disease, also known as globoid cell leukodystrophy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
GALC Gene-Disease associations (from GenCC):
  • Krabbe disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Myriad Women’s Health, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 94 curated pathogenic missense variants (we use a threshold of 10). The gene has 16 curated benign missense variants. Gene score misZ: 0.18582 (below the threshold of 3.09). Trascript score misZ: -0.94182 (below the threshold of 3.09). GenCC associations: The gene is linked to Krabbe disease.
BP4
Computational evidence support a benign effect (REVEL=0.091).
BP6
Variant 14-87963346-A-G is Benign according to our data. Variant chr14-87963346-A-G is described in ClinVar as Benign. ClinVar VariationId is 255369.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.154 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GALCNM_000153.4 linkc.1161+38T>C intron_variant Intron 10 of 16 ENST00000261304.7 NP_000144.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GALCENST00000261304.7 linkc.1161+38T>C intron_variant Intron 10 of 16 1 NM_000153.4 ENSP00000261304.2

Frequencies

GnomAD3 genomes
AF:
0.113
AC:
17183
AN:
152032
Hom.:
1138
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0400
Gnomad AMI
AF:
0.140
Gnomad AMR
AF:
0.130
Gnomad ASJ
AF:
0.119
Gnomad EAS
AF:
0.00231
Gnomad SAS
AF:
0.0953
Gnomad FIN
AF:
0.156
Gnomad MID
AF:
0.133
Gnomad NFE
AF:
0.156
Gnomad OTH
AF:
0.110
GnomAD2 exomes
AF:
0.126
AC:
31394
AN:
248394
AF XY:
0.126
show subpopulations
Gnomad AFR exome
AF:
0.0369
Gnomad AMR exome
AF:
0.144
Gnomad ASJ exome
AF:
0.116
Gnomad EAS exome
AF:
0.00201
Gnomad FIN exome
AF:
0.159
Gnomad NFE exome
AF:
0.155
Gnomad OTH exome
AF:
0.132
GnomAD4 exome
AF:
0.143
AC:
207088
AN:
1443132
Hom.:
16067
Cov.:
27
AF XY:
0.142
AC XY:
102468
AN XY:
719364
show subpopulations
African (AFR)
AF:
0.0342
AC:
1134
AN:
33118
American (AMR)
AF:
0.146
AC:
6515
AN:
44642
Ashkenazi Jewish (ASJ)
AF:
0.118
AC:
3079
AN:
25996
East Asian (EAS)
AF:
0.00164
AC:
65
AN:
39544
South Asian (SAS)
AF:
0.102
AC:
8746
AN:
85930
European-Finnish (FIN)
AF:
0.163
AC:
8683
AN:
53294
Middle Eastern (MID)
AF:
0.162
AC:
926
AN:
5728
European-Non Finnish (NFE)
AF:
0.155
AC:
170034
AN:
1095160
Other (OTH)
AF:
0.132
AC:
7906
AN:
59720
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
7959
15917
23876
31834
39793
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5844
11688
17532
23376
29220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.113
AC:
17192
AN:
152150
Hom.:
1141
Cov.:
32
AF XY:
0.113
AC XY:
8434
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.0400
AC:
1661
AN:
41544
American (AMR)
AF:
0.130
AC:
1985
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.119
AC:
413
AN:
3470
East Asian (EAS)
AF:
0.00232
AC:
12
AN:
5180
South Asian (SAS)
AF:
0.0951
AC:
459
AN:
4824
European-Finnish (FIN)
AF:
0.156
AC:
1647
AN:
10578
Middle Eastern (MID)
AF:
0.129
AC:
38
AN:
294
European-Non Finnish (NFE)
AF:
0.156
AC:
10620
AN:
67972
Other (OTH)
AF:
0.108
AC:
229
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
774
1548
2321
3095
3869
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
186
372
558
744
930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.134
Hom.:
2912
Bravo
AF:
0.107
Asia WGS
AF:
0.0550
AC:
192
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Galactosylceramide beta-galactosidase deficiency Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
12
DANN
Benign
0.64
PhyloP100
0.015
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17687109; hg19: chr14-88429690; COSMIC: COSV54324625; API